Midazolam Medical Valley 2.5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

midazolam medical valley 2.5 mg

medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 2.5 mg

Midazolam Medical Valley 5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

midazolam medical valley 5 mg

medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 5 mg

Midazolam Medical Valley 7.5 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

midazolam medical valley 7.5 mg

medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 7.5 mg

Midazolam Medical Valley 10 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

midazolam medical valley 10 mg

medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 10 mg

Xenleta यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibakterielle midler for systemisk bruk, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Sugammadex Piramal यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskulær blokkade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Suxamethonium chloride dihydrate Ethypharm 50 mg/ ml नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

suxamethonium chloride dihydrate ethypharm 50 mg/ ml

ethypharm (1) - suksametoniumkloriddihydrat - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml

Bridion यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

bridion

merck sharp & dohme b.v. - sugammadex - neuromuskulær blokkade - alle andre terapeutiske produkter - reversering av nevromuskulær blokade indusert av rocuronium eller vecuronium. for peadiatric befolkning: sugammadex er bare anbefalt for rutinemessig reversering av rocuronium-blokade indusert hos barn og unge.